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Abstract
Background: We have previously reported that low concentrations of cigarette smoke extract
induce DNA damage without leading to apoptosis or necrosis in human bronchial epithelial cells
(HBECs), and that IL-6/STAT3 signaling contributes to the cell survival. Since NF-κB is also involved
in regulating apoptosis and cell survival, the current study was designed to investigate the role of
NF-κB in mediating cell survival in response to cigarette smoke exposure in HBECs.
Methods: Both the pharmacologic inhibitor of NF-κB, curcumin, and RNA interference targeting
p65 were used to block NF-κB signaling in HBECs. Apoptosis and cell survival were then assessed
by various methods including COMET assay, LIVE/DEAD Cytotoxicity/Viability assay and colony
formation assay.
Results: Cigarette smoke extract (CSE) caused DNA damage and cell cycle arrest in S phase
without leading to apoptosis in HBECs as evidenced by TUNEL assay, COMET assay and DNA
content assay. CSE stimulated NF-κB -DNA binding activity and up-regulated Bcl-XL protein in
HBECs. Inhibition of NF-κB by the pharmacologic inhibitor curcumin (20 μM) or suppression of
p65 by siRNA resulted in a significant increase in cell death in response to cigarette smoke
exposure. Furthermore, cells lacking p65 were incapable of forming cellular colonies when these
cells were exposed to CSE, while they behaved normally in the regular culture medium.
Conclusion: The current study demonstrates that CSE activates NF-κB and up-regulates Bcl-XL
through NF-kB activation in HBECs, and that CSE induces cell death in cells lacking p65. These
results suggest that activation of NF-κB regulates cell survival following DNA damage by cigarette
smoke in human bronchial epithelial cells.
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Background
Cigarette smoke is the major preventable risk factor for a
variety of diseases including lung cancer and emphysema.
However, the mechanisms by which cigarette smoke
causes these varying diseases are not yet fully understood.
One key mechanism is believed to be the ability of ciga-
rette smoke to damage cellular DNA leading to the accu-
mulation of somatic cell mutations, which is believed to
contribute to the development of cancer and possible
chronic obstructive pulmonary disease as well [1]. In this
regard, cells can protect genomic integrity by activating
pathways of apoptosis in response to DNA damage. Ciga-
rette smoke-induced DNA damage, however, does not
always lead to apoptosis or necrosis [2,3]. In this content,
DNA repair can also be activated following DNA damage,
and the complex mechanisms that regulate whether DNA
damage leads to DNA repair or apoptosis have been the
subject of many recent studies [4-6].
We have previously reported that cigarette smoke induces
DNA damage in human bronchial epithelial cells and
lung fibroblasts without leading to apoptosis or necrosis
[2,3]. These cells repaired DNA damage and were capable
of proliferating and forming colonies when they were sub-
sequently sub-cultured in normal medium. Several signal-
ing pathways may be involved in modulating cell survival
or apoptosis in response to cigarette smoke-induced DNA
damage. Among these, NF-κB has been reported to play
an important role in mediating cell survival. In addition,
NF-κB is activated by cigarette smoke in vitro in cell culture
and in vivo in animal models of cigarette smoke exposure
[7,8]. Thus, the current study was designed to investigate
the role of NF-κB in modulating cell survival in human
bronchial epithelial cells exposed to cigarette smoke
extract. We demonstrated that cigarette smoke extract at
low concentration (5 and 10%) stimulated NF-κB -DNA
binding activity and up-regulated Bcl-XL in HBECs. Inhi-
bition of NF-κB by curcumin or suppression of p65 by
siRNA had no effect on control cell viability, but resulted
in increased cell death in cells exposed to cigarette smoke
extract. These results indicate that activation of NF-κB fol-
lowing DNA damage plays an important role in mediating
whether cell survival or apoptosis ensues.
Methods
Cell culture
The human bronchial epithelial cell line, BEAS-2B, was
obtained from the American Type Culture Collection
(CRL-9609; Rockville, MD). Normal human bronchial
epithelial cells (HBECs) were acquired from bronchial
biopsies of smokers with normal lung function using a
previously published method with modifications [9]
under a protocol approved by the University of Nebraska
Human Studies Committee. Both BEAS-2B and HBEC
cells were cultured in 100 mm tissue culture dishes (Fal-
con; BD Bioscience Discovery Labware, Bedford, MA),
which were coated with 0.03 mg/ml collagen (Vitrogen
100, Angiotech BioMaterials, Palo Alto, CA), in a 1:1 mix-
ture of LHC-9/RPMI 1640 [10,11]. Cells were passaged
once weekly at a 1:3 ratio. HBECs between the 3rd and
10th passage were used for experiments.
Antibodies for immunoblot
Following primary antibodies were purchased from Cell
Signaling Technology, Inc. (Danvers, MA): anti-Stat3,
anti-p65, anti-p50/p105, anti-Bcl-XL, anti-Bad, anti-Bax,
anti-Bcl2, and anti-XIAP antibodies. Anti-β-actin antibody
(A5441) was purchased from Sigma (St. Louise, MO).
Cigarette smoke extract (CSE) preparation
Cigarette smoke extract (CSE) was prepared with a modi-
fication of the method of Carp and Janoff [12]. Briefly,
one 100 mm long cigarette without filter (R1 Research
Grade Cigarette, University of Kentucky; these were
obtained prior to their being discontinued by the manu-
facturer and were stored (4°C) until use.) was combusted
with a Mini-Pump Variable Flow (Fisher Scientific, Pitts-
burgh, PA). The smoke was bubbled through 25 ml dou-
ble distilled water (ddH2O) at a speed of 70 cc/minute till
the unburned butt is less than 1 cm long. The resulting
suspension was in yellowish color and the optical density
(OD) value at 405 nm wave-length was 0.120 ± 0.020.
This solution was filtered through a 0.22 μm pore filter
(Lida Manufacturing Corp., Kenosha, WI) to remove bac-
teria and large particles. This filtered solution was consid-
ered to be 100% CSE and diluted with LHC-D/RPMI 1640
medium [10,11] within 30 minutes of preparation to
obtain the desired concentration used in each experiment.
The LHC-D/RPMI 1640 medium was a 1:1 mixture of
LHC-D and RPMI 1640, which contained no serum or
growth factors.
Quantitative TUNEL assay
DNA strand breaks were evaluated quantitatively with a
colorimetric kit (Titer TACS, Trevigen, Gaithersburg, CA)
that utilizes TUNEL stain in a 96-well format, following
the manufacturer's instructions. Briefly, cells were cul-
tured in 96-well plates till sub-confluent and treated with
desired concentrations of cigarette smoke extract. Cells
were then fixed with 3.7% Buffered Formaldehyde for 5
minutes followed by washing once with PBS. The cells
were post-fixed with 100% methanol for 20 minutes and
washed once with PBS. Cells were then labeled by TUNEL
following the manufacturer's instructions. Absorbance at
450 nm was measured with a Benchmark microplate
reader (Bio-Rad, Hercules, CA). For comparison, data are
expressed as % of Positive Control (DNAse treated cells),
according to the formula: (Sample OD value-blank)/(Pos-
itive Control OD value-blank) × 100.Respiratory Research 2008, 9:66 http://respiratory-research.com/content/9/1/66
Page 3 of 11
(page number not for citation purposes)
DNA content profiling by FACS analysis
To determine the presence of apoptotic cells, DNA con-
tent was measured by flow cytometry as reported previ-
ously [2]. Cells were cultured in 6-well plates till
confluent. After treatment with CSE or as a positive con-
trol, the DNA topoisomerase inhibitor camptothecin
(CPT), medium was harvested to collect floating cells and
attached cells were detached from the tissue culture dishes
with trypsin/EDTA. Both floating and attached cells were
then pelleted together and fixed with 70% ethanol at 4°C
for 30 minutes. After staining with propidium iodide (50
μg/106 cells, Sigma, St. Louis, MO), DNA content/cell
cycle analysis was performed by flow cytometry. Cells
with less DNA content than that of G1 cells (sub-G1 peaks
or A0 cells) were considered apoptotic.
COMET assay
Comet assay was performed using the CometAssay™ Kit
(Trevigen, Inc. Gaithersburg, MD). Briefly, cells were cul-
tured in 6-well plates and treated with cigarette smoke
extract or camptothecin as described above. Floating and
attached cells were harvested, pelleted and re-suspended
with cold PBS at 105 cells/ml. The resulting cell suspen-
sion (50 μL) was mixed with 500 μL of LMAgarose and 75
μL of the agarose/cells was pipetted over the sample area
of the COMET Slides. The samples were lysed, electro-
phoresed and stained following the manufacturer's
instructions. Cells were then viewed with an epifluores-
cence microscopy (NIKON Eclipse E800) and photo-
graphed with a digital camera (OPTRONICS) under 200×
magnification. Apoptotic index = number of cells with
small DNA head with fan-like tail/total cell number ×
100%.
Immunoblots
Cells were lysed with lysing buffer (50 mM Tris buffer, pH
7.4, containing 10 mM EDTA, 2 mM EGTA, 2 mM benza-
midine, 2.5 mM dithiothreitol, 2 μg/ml soybean trypsin
inhibitor, 100 μM tosyl-L-lysine chloromethyl ketone,
200 μM leupeptin, and 50 μM phenylmethylsulphonyl
fluoride). The cell lysate was centrifuged at 12,000 g for 10
minutes at 4°C and the precipitates were discarded. Pro-
tein concentrations in supernatants were determined by a
protein dye-binding assay (Bio-Rad, Hercules, CA). Pro-
teins were then subjected to immunoblot analysis. After
heating for 3 minutes at 95°C, 10 μg of total protein was
mixed with 2× sample buffer (0.5 M Tris-HCL, pH 6.8,
10% SDS, 0.1% bromphenol blue, 20% glycerol, 2% b-
mercaptoethanol) and loaded into each well before per-
forming electrophoresis with the Mini-protein 3 Cell Sys-
tem®  (Bio-Rad, Hercules, CA). The proteins were
transferred to PVDF membranes (Bio-Rad, Hercules, CA)
in transfer buffer (20 mM Tris, pH 8.0, 150 mM glycine,
20% methanol) at 20 V for 40 minutes with the semi-dry
electrophoretic transfer system (Bio-Rad, Hercules, CA).
The membrane was blocked with 5% dry-milk in PBS-
Tween at room temperature for 1 hour and then exposed
to primary antibodies at 4°C overnight. Target proteins
were subsequently detected using horseradish peroxidase
conjugated IgG with an enhanced chemiluminescence
detection system (ECL, Amersham Pharmacia Biotech,
Little Chalfont, Buckinghamshire, England).
Electrophoretic mobility shift assay (EMSA)
Electrophoretic mobility shift assay (EMSA) was per-
formed with a kit (Panomics, Inc, Redwood city, CA) fol-
lowing the manufacturer's instructions. Briefly, nuclear
extract (5 μg) was incubated with 10 ng biotin-labeled NF-
κB (p65) probe. For the "cold probe" assay, 20 ng of unla-
beled (cold) NF-kB probe was mixed with sample 5 min-
uets before adding 10 ng biotin-labeled NF-kB probe
(cold vs labeled probe ratio was 2:1). Protein-DNA com-
plexes were then resolved by non-denaturing polyacryla-
mide gel electrophoresis (PAGE). After transfer to Pall
Biodyne B® membrane (Pall Corporation, East Hills, NY),
proteins were immobilized in UV cross-linker. After
blocking, avidin-HRP was applied and detected by
enhanced chemiluminescence (ECL, Amersham).
RNA interference
Targeting p65 siRNA and non-targeting control siRNA
(Dharmcon, Inc, Lafayette, CO) were introduced into the
cells using a method previously described with modifica-
tion [13]. Briefly, normal human bronchial epithelial cells
were plated into V30-coated 60 mm dishes at a density of
106 /dish so that the cells were 60–70% confluent after 1–
2 days. At that time, after washing with PBS, cells were
treated with Lipofectamine 2000 (Invitrogen, Carlsbad,
CA) containing p65-siRNA, STAT3-siRNA or non-target-
ing control siRNA (final concentration 100 nM in Opti-
MEM) for 6 hours followed by re-feeding with LHC-9/
RPMI medium. On the next day, cells were trypsinzed and
counted. One half million cells were used to examine the
silencing effect. The remainder of the cells were plated
into 6-well plates and exposed to cigarette smoke on the
next day.
LIVE/DEAD staining
Cell viability was evaluated by ethidium homodimer-1
dye exclusion using the LIVE/DEAD Kit, following the
manufacturer's instructions (Invitrogen, Carlsbad, CA).
Briefly, cells were detached by trypsinization and incu-
bated in LHC-D/RPMI medium containing Calcein AM
(Green) and ethidium homodimer-1 (EthD-1, Red) at
37°C for 15 minutes. Cells were then spun onto slides by
cytospin followed by observation under fluorescence
microscopy within 24 hrs. Nuclei stained by EthD-1,
which appeared red, were counted as dead cells. Cell
number was counted in 5 randomly chosen fields and
expressed as percent of dead cells (number of red nuclearRespiratory Research 2008, 9:66 http://respiratory-research.com/content/9/1/66
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stained cells/total cell number). In general, at least 300
cells were counted.
Clonogenic assay
Assay of clongenic growth was performed with a modifi-
cation of the previously reported methods [14]. Briefly,
cells were cultured in 6-well plates and treated with CSE or
camptothecin for 24 hours. Both floating and attached
cells were harvested. After counting the cell number, cells
were plated in non-coated 60 mm tissue culture dishes at
103 cells/ml, 5 ml/dish in LHC-9/RPMI. Cells were main-
tained in culture for 7–10 days with medium changes
every 2–3 days. Cells were then fixed with PROTOCOL
(Fisher Diagnostics. Middletown, VA) and photographed.
All colonies present in each well, defined as a cluster of 20
or more cells, were counted visually.
Statistical analysis
All data are expressed as mean ± standard error of the
mean. Statistical comparisons of multi-group data were
analyzed by analysis of variance (ANOVA) followed by
student's t test for values that appeared different with the
Tukey's (one-way) or Bonferroni's (two-way) post-test
correction for multiple comparisons using PRISM4 soft-
ware. P < 0.05 was considered significant.
Results
Cigarette smoke extract induces DNA damage without leading
to apoptosis Cigarette smoke induced DNA damage in
human bronchial epithelial cells as evidenced by TUNEL
positivity (Figure 1A). To further determine if apoptosis
occurred in these DNA-damaged cells, confluent HBECs
were treated with 10% CSE or 0.5 μM camptothecin. DNA
content by FACS analysis and DNA damage/apoptosis by
COMET assay were then evaluated. Compared to medium
alone (control), 10% cigarette smoke extract did not
increase apoptosis in human bronchial epithelial cells as
evaluated by either DNA content or COMET assay (Figure
1B and 1C). In contrast, camptothecin induced apoptosis
in these cells as evidenced by a sub-G1 peak (14.6 ± 1.8%,
Figure 1B) or cells with a small DNA head and fan-like tail
in the COMET image (apoptotic index: 43.5% ± 8.9%,
Figure 1C). Cigarette smoke, however, led to cell cycle
arrested in S phase (Figure 1B, 40.2 ± 3.8% vs 25.9 ± 2.9%
of control, p < 0.01). Furthermore, cells with DNA dam-
age, if allowed to recover, were able to proliferate and
form colonies in subsequent culture (Figure 1D). In addi-
tion, necrosis was not induced by cigarette smoke extract
(10% or lower) as evidenced by both MTT and LDH assay
(data not shown).
Effect of cigarette smoke on NF-κB activation
Since NF-κB is involved in regulating cell death and sur-
vival in variety of cell types, activation of NF-κB in
response to cigarette smoke exposure was investigated by
EMSA. Cigarette smoke extract (5% and 10%) stimulated
DNA binding activity of NF-κB as evidenced by the elec-
trophoresis mobility shift assay (Figure 2).
Role of NF-κB in modulating cell survival in response to 
cigarette smoke exposure
To investigate the role of NF-κB in modulating cell sur-
vival, both the pharmacological inhibitor of NF-κB, curcu-
min, and RNA interference targeting p65 were used in the
current study. Neither 10% CSE nor curcumin (up to 20
μM) alone affected cell viability as examined by LIVE/
DEAD Cytotoxicity and Viability assay (Figure 3). When
cigarette smoke extract and curcumin were added
together, however, the number of dead cells was signifi-
cantly increased (41.4 ± 1.2% of CSE plus curcumin vs
11.9 ± 1.8% of control, p < 0.01, Figure 3B).
The role of NF-κB in mediating cell survival was further
investigated by small RNA inference of p65. Following
transfection with p65-siRNA, the expression of p65 was
suppressed nearly 100%; in contrast, there was little effect
on p50 or β-actin, but an apparent increase in expression
of STAT3, which was specifically suppressed by STAT3
siRNA (Figure 4).
Following transfection with p65-siRNA, HBEC cells were
exposed to cigarette smoke extract for 24 hours. Cell death
or survival was then evaluated by three different methods
including LIVE/DEAD staining, COMET assay and clono-
genic assay. Only the combination of p65-siRNA suppres-
sion and smoke exposure resulted in major cytotoxicity.
In the presence of 10%CSE, the cells lacking p65 started to
detach at 3–4 hrs after exposure to cigarette smoke and
nearly all of the cells were detached from the culture dish
after 24 hours exposure. In contrast, only a few cells in the
control-siRNA treated group detached in response to ciga-
rette smoke exposure. LIVE/DEAD staining demonstrated
that very few cells were dead (red nuclei) in the non-tar-
geting siRNA transfected cells (Figure 5A, 3.5 ± 0.3%), in
the cells of p65-siRNA transfected without cigarette smoke
exposure (Figure 5A, 7.0 ± 1.1%) or in non-targeting
siRNA transfected cells exposed to 10% cigarette smoke
(Figure 5A, 2.4 ± 1.0%). In contrast, nearly half of the cells
were dead in the cells transfected with p65-siRNA and
exposed to cigarette smoke extract (Figure 5A, 32.5 ±
1.8%, p < 0.01 compared to control siRNA transfected
cells without exposure to cigarette smoke extract), which
was similar to the cells exposed to camptothecin (data not
shown). Consistent with LIVE/DEAD cytotoxicity assay,
p65-depleted cells underwent severe DNA damage and
apoptotic death when they were exposed to cigarette
smoke as evidenced by COMET assay (Figure 5B). The
apoptotic index was significantly higher in the cells lack-
ing p65 and exposed to cigarette smoke (42.5 ± 6.5% vs
6.3 ± 1.2% of control, p < 0.01).Respiratory Research 2008, 9:66 http://respiratory-research.com/content/9/1/66
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To further evaluate cell survival and ability to proliferate,
clonogenic assay was performed. As shown in Figure 5C,
neither cigarette smoke exposure of the non-targeting
siRNA transfected cells (92.6 ± 14.9 colonies/dish) nor
the p65-siRNA transfection alone (80.6 ± 8.1 colonies/
dish) altered the ability of the cells to form colonies. How-
ever, cigarette smoke exposure of the p65-suppressed cells
resulted in a significant decrease in colony formation (3.4
± 1.4 colonies/dish, p < 0.01 compared to non-targeting
siRNA transfection without cigarette smoke exposure 85.6
± 9.6 colonies/dish). Similarly, colony formation was sig-
nificantly decreased in camptothecin-treated cells (3.6 ±
1.1 colonies/dish, p < 0.01 compared to non-targeting
siRNA transfection without cigarette smoke exposure).
Role of NF-κB in regulating anti-apoptotic protein Bcl-XL
To explore the mechanism of NF-κB prevent HBEC from
death in response to cigarette smoke exposure, effect of
cigarette smoke on anti-apoptotic protein synthesis was
investigated. As shown in Figure 6A, cigarette smoke sig-
nificantly stimulated anti-apoptotic protein Bcl-XL with
strongest effect at 5%CSE. CSE also slightly stimulated
Effect of cigarette smoke on human bronchial epithelial cell DNA damage and survival Figure 1
Effect of cigarette smoke on human bronchial epithelial cell DNA damage and survival. Human bronchial epithelial 
cells were exposed to 10% cigarette smoke extract for 24 hours or to 0.5 μM camptothecin for 4 hours, respectively, in LHC-
D/RPMI medium. Both floating and attached cells were harvested, combined and used for TUNEL assay (Panel A), DNA con-
tent profiling and cell cycle analysis (Panel B), COMET assay (Panel C) and colony formation assay (Panel D). Data presented in 
panels A, C and D is one representative experiment from at least 4 replicates in both BEAS-2B and HBEC cells. Panel B is an 
average of 8 different experiments for "control and CSE", and 4 different experiments for camptothecin (CPT) treated. * p < 
0.05, ** p < 0.01 compared to control. Panel C: arrow heads indicate cells with DNA damage, and arrows indicate cells under-
going apoptosis with a typical fan-like tail and small head.Respiratory Research 2008, 9:66 http://respiratory-research.com/content/9/1/66
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Bcl2, another anti-apoptotic protein, but did not affect
levels of pro-apoptotic proteins, Bax and Bad. Further-
more, up-regulation of Bcl-XL by CSE in HBECs was sig-
nificantly reduced in the cells lacking of p65 (Figure 6B).
Discussion
The current study demonstrated that cigarette smoke
extract activates NF-κB as evidenced by DNA binding
activity, and by this mechanism, blocks cell death follow-
ing DNA damage in response to cigarette smoke exposure
in human bronchial epithelial cells. The inhibition of NF-
κB activity by a pharmacologic inhibitor (curcumin) or
suppression of p65 by siRNA results in a significant
increase in apoptotic cell death in response to cigarette
smoke exposure, indicating NF-κB regulates cell survival
of human bronchial epithelial cells following cigarette
smoke-induced DNA damage.
Cigarette smoke contains over six thousand chemical
compounds that are delivered to the lungs as a gas, as an
aerosol or as particles. Many of these toxins can cause
DNA damage or strand breakage. In response to DNA
damage, cells can either repair the damage or can protect
the integrity of the genome by activation of pathways
leading to programmed cell death, i.e. apoptosis [15,16].
Should apoptosis fail to remove cells with irreversibly
damaged DNA, this may result in epigenetic changes or
somatic cell mutation, which could lead to altered tissue
function and, potentially, to the development of cancer or
other disease. Here, we report that cigarette smoke
induces not only DNA damage, but also cell cycle arrest in
S phase. These cells, however, did not undergo apoptosis.
In contrast, the cells exposed to cigarette smoke recovered
following removal of the cigarette smoke and could pro-
liferate and form colonies. Similar findings have been
reported by Bayram et al in diesel exhaust particle exposed
human lung epithelial cells and by Narayan et al in ciga-
rette smoke exposed human breast epithelial cells in vitro
[17,18].
Cell cycle arrest allows more time for DNA repair follow-
ing DNA damage. Timely progression of cell cycles is reg-
ulated by a series of specific check-point kinase (CHK1,
CHK2), cyclin-dependent kinases (cdks) and their inhibi-
tors (cdkIs) [19,20]. The most potent cdkIs are p21, p27,
p57 and p16 [21]. Activation of these cdkIs leads to G1/S
phase cell cycle arrest in response to DNA damage [22-
24]. In contrast, suppression or deficiency of p21 protein
leads the cells to undergo apoptosis through extensive
cytochrome c release and caspase activation in response to
DNA damage [25,26]. It has been reported that cells with
activated NF-kB in response to DNA damage had pro-
longed cell cycle arrest time followed by cell survival [27].
In contrast, cells that failed to activate NF-kB underwent
transient cell cycle arrest and extensive cell death [27].
Furthermore, induction of p21 in the arrested cells was
NF-kB dependent and suppression of p21 by siRNA
reduced NF-kB-mediated cell survival [27]. However,
whether p21 also regulates cell cycle arrest in human
bronchial epithelial cells in response to cigarette smoke-
induced DNA damage remains to be determined.
Whether a cell undergoes apoptosis or survival following
DNA damage is controlled by a complex interaction of
many signaling pathways [28-31]. Among these, NF-κB is
believed to play an important role in regulating cell sur-
vival by up-regulating anti-apoptotic proteins [27,32-34].
NF-κB is a family of transcription factors that can form
either homo- or heterodimers. Five distinct chains (RelA
(p65), RelB, cRel, p50/p105, p52/100) comprising NF-κB
have been described, providing considerable heterogene-
ity. Latent forms are retained in the cytoplasm bound to a
class of inhibitory proteins termed IκBs [35]. A large
number of stimuli are capable of activating a family of
kinases termed IκB kinase (IKK), which phosphorylates
IκB, and leads to its degradation. This results in unbound
NF-κB that is then free to enter the nucleus to modulate
Effect of cigarette smoke on NF-κB and DNA binding Figure 2
Effect of cigarette smoke on NF-κB and DNA bind-
ing. Cells were exposed to 0, 5 and 10% CSE or TNF-a (10 
ng/ml) for 30 minutes in LHC-D/RPMI medium. Nuclear pro-
teins were extracted and subjected for EMSA as described in 
the methods. Data presented are one representative of 3 
separate experiments with similar results.Respiratory Research 2008, 9:66 http://respiratory-research.com/content/9/1/66
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gene expression. Many inflammatory stimuli and injuri-
ous insults, including cigarette smoke, can activate NF-κB
[7,36-38]. Consistent with previous reports [7,8,39,40],
we found that cigarette smoke extract stimulates NF-κB
DNA binding activity in human bronchial epithelial cells.
We have previously reported that cigarette smoke extract
induces DNA damage without leading to apoptosis [2],
and that the IL-6/STAT3 pathway plays a role in mediating
cell survival in response to cigarette smoke exposure [13].
Here, we extend these previous studies by demonstrating
that inhibition of NF-κB signaling by curcumin or sup-
pression of p65 by siRNA also results in increased cell
death of bronchial epithelial cells in response to cigarette
smoke extract. This indicates that NF-κB is also involved
in regulating cell survival following cigarette smoke-
induced DNA damage. The downstream mechanisms by
which NF-κB mediates cell survival remains to be further
defined. However, like IL-6/STAT3 [13], NF-κB can mod-
ulate the production of a number of pro- and anti-apop-
totic proteins, especially, Bcl-XL. This suggests that
Effect of NF-κB inhibitor on the viability of HBEC exposed to cigarette smoke extract Figure 3
Effect of NF-κB inhibitor on the viability of HBEC exposed to cigarette smoke extract. Cells were pre-treated 
with 20 μM curcumin for 30 minutes followed by exposure to 10% cigarette smoke extract for 24 hours in the presence or 
absence of curcumin. Cell viability and cytotoxicity were determined by LIVE/DEAD assay. Panel A: One representative micro-
photograph of LIVE/DEAD staining. Green: live cells; Red: dead cells. Magnification: 200×. Panel B: Quantitative data from 3 
separate experiments. Vertical axis: percent of dead cells = red cells/(green cells + read cells) * 100%. Horizontal axis: treat-
ment.
Specific suppression of p65 by siRNA Figure 4
Specific suppression of p65 by siRNA. HBECs were 
transfected with control-siRNA, p65-siRNA or STAT3-
siRNA for 6 hours as described in the methods. Cells were 
maintained in culture for additional 72 hours. Cell lysates 
were then subjected to immunoblot for p65, p50, STAT3 and 
β-actin. Data presented are one representative of 4 separate 
experiments.Respiratory Research 2008, 9:66 http://respiratory-research.com/content/9/1/66
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multiple pathways that may interact by regulating the net-
work of proteins that in turn modulate apoptosis are
required to sustain cell survival in the face of DNA damage
induced by cigarette smoke.
In the current study, the pharmacologic inhibitor curcu-
min was used to inhibit NF-κB signaling. Curcumin [1,7-
bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-
dione] is the major bioactive compound in turmeric (Cur-
cuma longa) with reported antioxidant, anti-inflamma-
tory, anti-carcinogenic, and anti-mutagenic effects
[41,42]. Inhibition of NF-κB activity by curcumin sensi-
tizes cancer cells to chemotherapy, inhibits cell growth,
and induces apoptosis in cancer cells [43,44]. Consistent
with this, our data demonstrate that curcumin sensitizes
bronchial epithelial cells to undergo apoptotic death in
response to a low concentration of cigarette smoke extract
that would otherwise cause DNA damage without cell
death and that this effect is dependent on NF-κB activity.
Curcumin, however, inhibits not only NF-κB, but also
other transcription factors including AP-1 and STATs, and
kinases such as protein kinases and MAPKs [45-47].
Therefore, in addition to curcumin, an RNAi strategy spe-
cifically targeting p65 was also used in the current study.
Suppression of p65 by RNAi has been reported previously
[48,49]. In the current study, we demonstrated that p65-
siRNA very efficiently and specifically suppressed p65 pro-
duction without affecting non-targeted STAT3, p50 and β-
actin in human bronchial epithelial cells. Suppression of
p65 by RNAi per se does not alter cell viability or the abil-
ity of cells to proliferate. Cell death only occurred when
the cells lacking p65 were exposed to cigarette smoke,
indicating p65 is required for protection of the cells from
cigarette smoke insult.
It has been reported that NF-kB modulates cell survival or
death in many cell types through regulating expression of
apoptosis associated proteins [34,50-52]. Constitutive
Role of p65 in mediating HBEC survival in response to cigarette smoke exposure Figure 5
Role of p65 in mediating HBEC survival in response to cigarette smoke exposure. Following transfection with p65-
siRNA, HBECs were exposed to 10% CSE for 24 hours. Cells were then harvested and used for LIVE/DEAD cytotoxicity/via-
bility assay (Panel A), COMET assay (Panel B) and colony formation assay (Panel C) as described in the methods. Data in panel 
A and B are one representative from 3 separate experiments, and panel C is an average of 3 separate experiments each per-
formed in triplicate dishes. Panel B: arrow heads indicate cells with DNA damage, and arrows indicated cells undergoing apop-
tosis.Respiratory Research 2008, 9:66 http://respiratory-research.com/content/9/1/66
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activation of NF-kB contributes to the survival of cancer
cells while inhibition of NF-kB sensitizing the cells to
undergo apoptosis in response to chemotherapy or radio-
therapy [53-55]. In the current study, we demonstrated
that an anti-apoptotic protein, Bcl-XL, was significantly
up-regulated by cigarette smoke in HBECs and this was
abolished by introduction of p65 siRNA prior to cigarette
smoke exposure. These results suggest that NF-kB regu-
lates HBEC survival, at least in part, through up-regulating
the anti-apoptotic protein, Bcl-XL. Cell survival, however,
depends on a balance of many factors, and it seems likely
that NF-kB will modulate factors other than Bcl-XL.
Effect of cigarette smoke on human being is determined
by many factors such as type of cigarette, manner of smok-
ing and history of smoking. In the current study, an in vitro
cell culture model was used to study the effect of cigarette
smoke on human airway cells. This in vitro cell culture
model has its limitations as it differs from in vivo condi-
tions. In this study, the cells were in submerged culture
condition and were exposed to CSE in tissue culture
media without protein supplementation. It is likely that
the in vivo exposure of cells to toxins in inhaled smoke will
differ, both due to the different concentrations of toxins
and to the modulatory effects of proteins and other factors
present in the cellular milieu. Despite these limitations,
however, in vitro experiments with the design utilized in
the current study have a long history of providing useful
information [56,57]. In this regard, the calculated concen-
tration of acrolein in our fresh medium (2.16 × 10–5 M)
is similar to that reported by others [58] and to that inhib-
its lung fibroblasts repair functions [59]. Furthermore, the
key in vitro findings of the current study, that NF-κB medi-
ates bronchial epithelial cell survival following DNA dam-
age by cigarette smoke exposure provides evidence for a
potential mechanism by which cigarette smoke may cause
epigenetic changes or somatic cell mutation.
Conclusion
The current study demonstrates that cigarette smoke
extract not only induces DNA damage and cell cycle arrest
without leading to apoptosis, but also stimulates NF-κB -
DNA binding activity and up-regulates Bcl-XL, and that
NF-kB is required for CSE induced inhibition of apoptosis
through Bcl-XL up-regulation. By damaging DNA and
simultaneously inhibiting apoptosis through NF-kB sign-
aling pathway, cigarette smoke may be able to cause either
epigenetic changes or somatic cell mutation. Either of
these could lead to altered cellular function and could
contribute to chronic diseases such as cancer and chronic
obstructive pulmonary disease.
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